Step 1 – Today
₹25 Cr raised for 20%
Valuation: ₹125 Cr
Step 2 – Growth
55% CAGR → over 3 years
Step 3 – Reality
Company value: ₹465 Cr
Your 20% = ₹93 Cr
Equity is the most expensive form of Capital
The real cost of equity is not dilution today, it is the future growth you give away.
Equity cost ≠ ₹25 Cr
Equity cost = ₹93 Cr of future value
Equity only makes sense when the investor helps you grow faster, smarter, or larger than you could on your own.
Otherwise, it becomes the most expensive capital you’ll ever raise.
During this Assesment, we focus on three critical areas
Together, these help us identify the right investor, not just available capital.
01. Business & Offering Fit
Who should back this business?
We evaluate whether your healthcare offering is structurally attractive to external capital.
We assess:
-
The strength and scalability of your core healthcare offering
-
Where genuine expansion opportunities exist (not theoretical ones)
-
Which types of investors truly align with your business model and can strengthen or expand the offering beyond capital alone
02. GTM & Market Expansion Fit
Who can help you grow beyond where you are today?
We examine whether external capital can realistically accelerate your next phase of growth.
We assess:
-
Your current go-to-market approach
-
Which investors can deepen penetration in existing markets
-
Who can credibly support expansion into new cities, regions, or geographies
03. Capital Structure & Financial Efficiency
What is the cheapest form of capital for your business right now?
We determine whether raising capital is necessary and if so, what form it should take.
We assess:
-
Your current financial position
-
Whether growth can be funded internally
-
The optimal mix of equity and debt to minimise long-term cost of capital
This assessment is not about raising capital faster. It is about raising capital right.
Process
Intake
Review
Discussion
Summary
You share essential financials and business context.
We assess capital fit, structure, and readiness.
We discuss insights, gaps, and strategic options.
You receive a written
verdict and recommended next steps.
What you get from this assesment
A clear, written summary from industry experts with 25+ years of experience, covering:
-
Investor–Business Fit
Product expansion leverage
Go-to-market and scale leverage investors can bring -
Capital Structure Clarity
The right mix of equity and debt to minimise long-term cost -
Key Risks & Blind Spots
What could weaken your raise or valuation before going to market
This clarity becomes a strategic advantage, keeping you one step ahead of the competition.
Submit your company profile for a discovery call
Share a brief overview of your business and financials. We review every submission before scheduling a discovery call to assess fit, readiness, and scope.